Prosecution Insights
Last updated: October 04, 2026

Corflow Therapeutics AG

Technology area: Medical Devices & Mechanical Engineering

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Analysis

Corflow Therapeutics AG maintains 1 pending office action within the Medical Devices & Mechanical Engineering technology area. This action is distributed to 1 distinct examiner and 1 distinct art unit, indicating a very focused prosecution presence at the patent office. The involvement of only 1 examiner suggests that the company's current filings are concentrated on a specific medical device or mechanical innovation.

The busiest examiner identified is HALL, DEANNA K, who is currently responsible for 1 pending office action. Since the total pending office actions for the company is 1, this examiner handles the entirety of the active workload. This 1 to 1 ratio between the busiest examiner's load and the total pending actions reflects a streamlined interaction where the company's immediate success depends on the review of HALL, DEANNA K.

For practitioners, the presence of 1 distinct art unit and 1 distinct examiner for the 1 pending office action provides a clear and direct path for prosecution. There are no competing examination styles or different unit standards to navigate, as all current activity is centralized. This focused profile in the Medical Devices & Mechanical Engineering sector allows the applicant to dedicate all resources to resolving the issues raised in the single pending office action.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Double-patenting + other1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
HALL, DEANNA K 1 75.7% +15.7%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18634528 SYSTEM AND METHODS FOR TREATING MVO HALL, DEANNA K —

Top Art Units

Art UnitApps
3783 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18634528 SYSTEM AND METHODS FOR TREATING MVO HALL, DEANNA K 3783 §112DP Non-Final OA — Pending Apr 12, 2024

Managing Corflow Therapeutics AG's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month